InChI | InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1 |
Reference | </br>1:[Synergistic anti-tumor effect of obatoclax and MG-132 in esophageal cancer cell line CaES-17]. Zhao XY, Lin QH, Que FC, Gu CP, Yu L, Liu SW.Nan Fang Yi Ke Da Xue Xue Bao. 2016 Apr;36(4):506-13. Chinese. PMID: 27113178 </br>2:Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein. Zhou W, Zhu W, Ma L, Xiao F, Qian W.Oncol Lett. 2015 Nov;10(5):2899-2904. Epub 2015 Sep 2. PMID: 26722260 Free PMC Article</br>3:Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells. Liu D, Gao M, Yang Y, Qi YU, Wu K, Zhao S.Oncol Lett. 2015 May;9(5):2278-2282. Epub 2015 Mar 17. PMID: 26137056 Free PMC Article</br>4:Chemically assisted somatic cell nuclear transfer without micromanipulator in the goat: effects of demecolcine, cytochalasin-B, and MG-132 on the efficiency of a manual method of oocyte enucleation using a pulled Pasteur pipette. Hosseini SM, Hajian M, Forouzanfar M, Ostadhosseini S, Moulavi F, Ghanaei HR, Gourbai H, Shahverdi AH, Vosough AD, Nasr-Esfahani MH.Anim Reprod Sci. 2015 Jul;158:11-8. doi: 10.1016/j.anireprosci.2015.04.002. Epub 2015 Apr 15. PMID: 25956201 </br>5:Upregulated ROS production induced by the proteasome inhibitor MG-132 on XBP1 gene expression and cell apoptosis in Tca-8113 cells. Chen HY, Ren XY, Wang WH, Zhang YX, Chen SF, Zhang B, Wang LX.Biomed Pharmacother. 2014 Jul;68(6):709-13. doi: 10.1016/j.biopha.2014.07.011. Epub 2014 Jul 18. PMID: 25092240 </br>6:MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB. Skalniak L, Dziendziel M, Jura J.Mol Cell Biochem. 2014 Oct;395(1-2):253-63. doi: 10.1007/s11010-014-2134-z. Epub 2014 Jul 4. PMID: 24992982 Free PMC Article</br>7:Nigrostriatal pathway degeneration in rats after intraperitoneal administration of proteasome inhibitor MG-132. Wójcik S, Spodnik JH, Spodnik E, Dziewiątkowski J, Moryś J.Folia Neuropathol. 2014;52(1):41-55. PMID: 24729342 Free Article</br>8:The role of Src protein in the process formation of PC12 cells induced by the proteasome inhibitor MG-132. Tarjányi O, Berta G, Harci A, Bacsa EB, Stark B, Pap M, Szeberényi J, Sétáló G Jr.Neurochem Int. 2013 Nov;63(5):413-22. doi: 10.1016/j.neuint.2013.07.008. Epub 2013 Jul 31. PMID: 23911694 </br>9:Proteasome inhibitor MG-132 induces MCPIP1 expression. Skalniak L, Koj A, Jura J.FEBS J. 2013 Jun;280(11):2665-74. doi: 10.1111/febs.12264. Epub 2013 May 7. PMID: 23551903 Free PMC Article</br>10:Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB. Wang Y, Sun W, Du B, Miao X, Bai Y, Xin Y, Tan Y, Cui W, Liu B, Cui T, Epstein PN, Fu Y, Cai L.Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H567-78. doi: 10.1152/ajpheart.00650.2012. Epub 2012 Dec 7. PMID: 23220333 Free Article
|